Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Fluorodeoxyglucose F18 × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Stomach Neoplasms 5 Carcinoma, Transitional Cell 5 Uterine Cervical Neoplasms 4 Sarcoma 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Thyroid Neoplasms 3 Neuroendocrine Tumors 3 Neoplasms 3 Cholangiocarcinoma 3 Anus Neoplasms 3 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Pheochromocytoma 2 Paraganglioma 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Hodgkin Disease 2 Carcinoma, Renal Cell 2

Interventions

Taxes 4 Paclitaxel 3 Cyclophosphamide 3 exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Doxorubicin 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 romidepsin 1 ribociclib 1 pegfilgrastim 1 entinostat 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Trastuzumab 1 Psychiatric Rehabilitation 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Lapatinib 1 Indomethacin 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡